PFIZER, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.44 USD | +1.54% |
|
+0.99% | -1.22% |
ETFs positioned on Pfizer, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.89% | 121 M€ | +6.79% | - | |
| 0.88% | 204 M€ | +10.54% | ||
| 0.85% | 8 M€ | +5.74% | - | |
| 0.85% | 744 M€ | +8.55% | ||
| 0.84% | 9 M€ | +8.59% | ||
| 0.82% | 104 M€ | +8.99% | ||
| 0.78% | 265 M€ | +5.36% | - | |
| 0.75% | 1 M€ | +0.04% | ||
| 0.75% | 559 M€ | +14.30% | ||
| 0.75% | 1,848 M€ | +18.39% | - | |
| 0.72% | 2,517 M€ | +12.13% | - | |
| 0.70% | 57 M€ | +20.49% | - | |
| 0.65% | 8 M€ | +5.48% | - | |
| 0.63% | 7 M€ | +6.22% | - | |
| 0.60% | 283 M€ | +19.39% | ||
| 0.60% | 50 M€ | +9.46% | ||
| 0.60% | 273 M€ | -.--% | ||
| 0.60% | 1,174 M€ | +23.54% | ||
| 0.60% | 655 M€ | -.--% | - | |
| 0.59% | 22 M€ | +14.86% | ||
| 0.54% | 414 M€ | +11.88% | - | |
| 0.54% | 1,006 M€ | -.--% | - | |
| 0.54% | 3 M€ | +15.16% | - | |
| 0.54% | 13 M€ | -.--% | - | |
| 0.54% | 4 M€ | -.--% | - | |
| 0.52% | 1 M€ | -.--% | ||
| 0.52% | 284 M€ | -.--% | ||
| 0.51% | 29 M€ | -.--% | - |
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.44
USD
Average target price
31.94
USD
Spread / Average Target
+12.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.22% | 161B | |
| +29.98% | 682B | |
| +32.24% | 586B | |
| -3.52% | 364B | |
| +18.59% | 327B | |
| +4.07% | 285B | |
| +16.42% | 240B | |
| +9.46% | 209B | |
| -8.88% | 203B | |
| +7.09% | 165B |
- Stock Market
- Equities
- PFE Stock
- Funds and ETFs Pfizer, Inc.